Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Baxter launches renal disease management assets:

This article was originally published in Clinica

Executive Summary

The leader in renal equipment production, Baxter Healthcare has launched an affiliate, Renal Management Strategies (RMS). The new division is intended to offer a service to nephrologists operating in the financially straightened healthcare environment of the 1990s. RMS will provide a nationwide service enabling physicians treating people with end-stage renal disease (ESRD) to obtain the most comprehensive capitated contracts from third-party payers. Patients, argues Baxter, will benefit from access to managed care tailored to ESRD, whilst nephrologists will have access to clinical support and data enabling them to balance clinical need with cost.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT089447

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel